Skip to main content
Log in

A Phosphinic Acid Dipeptide Analogue to Stabilize Peptide Drugs During Their Intranasal Absorption

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

A major challenge in intranasal delivery of peptides is to overcome the enzymatic barrier that limits their absorption. Aminopeptidase inhibitors may be useful for improving systemic delivery of peptide drugs administered nasally. A phosphinic acid dipeptide analogue, a transition-state analogue aminopeptidase inhibitor in which the phosphinate moiety exists in a tetrahedral state mimicking peptides during their enzymatic hydrolysis, was synthesized and tested nasally in situ in rats. This inhibitor was found to inhibit greatly the degradation of the model peptide leucine-enkaphalin in the nasal perfusate at ≤2 µM concentrations. The nasal peptidase hydrolytic activity was reversible after exposure to the inhibitor. This inhibitor has the advantage of efficacy at very low concentrations and reversibility of effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. M. A. Hussain, A. B. Shenvi, S. M. Rowe, and E. Shefter. The use of α-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption. Pharm. Res. 6:186–189 (1989).

    Google Scholar 

  2. M. A. Hussain, C. A. Koval, A. B. Shenvi, and B. J. Aungst. An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases. Life Sci. 47:227–231 (1990).

    Google Scholar 

  3. M. A. Hussain, C. A. Koval, A. B. Shenvi, and B. J. Aungst. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors. J. Pharm. Sci. 79:398–400 (1990).

    Google Scholar 

  4. P. P. Giannousis and P. A. Bartlett. Phosphorous amino acid analogues as inhibitors of leucine aminopeptidase. J. Med. Chem. 30:1603–1609 (1987).

    Google Scholar 

  5. E. K. Baylis, C. D. Campbell, and J. D. Dingwall. 1-Aminoalkylphosphonous acids. I. Isosteres of the protein amino acids. J. Chem. Soc. Perkin Trans. 1:2845–2853 (1984).

    Google Scholar 

  6. W. H. Parsons, A. A. Patchett, H. G. Bull, W. R. Schoen, D. Taub, J. Davidson, P. L. Combs, J. P. Springer, H. Gadebusch, B. Weissberger, M. E. Valiant, T. N. Mellin, and R. D. Busch. Phosphinic acid inhibitors of D-alanyl-D-alanine ligase. J. Med. Chem. 31:1772–1778 (1988).

    Google Scholar 

  7. R. E. Stratford and V. H. L. Lee. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: implications in peptide delivery. Int. J. Pharm. 30:73–82 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussain, M.A., Lim, M.S.L., Raghavan, K.S. et al. A Phosphinic Acid Dipeptide Analogue to Stabilize Peptide Drugs During Their Intranasal Absorption. Pharm Res 9, 626–628 (1992). https://doi.org/10.1023/A:1015845925668

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015845925668

Navigation